Leslie L. Trigg - 17 Jan 2025 Form 4 Insider Report for Outset Medical, Inc. (OM)

Signature
By: John L Brottem For: Leslie Trigg
Issuer symbol
OM
Transactions as of
17 Jan 2025
Net transactions value
-$52,189
Form type
4
Filing time
22 Jan 2025, 18:05:34 UTC
Previous filing
13 Jan 2025
Next filing
19 Feb 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Award $0 +99,419 +12% $0.000000 960,816 17 Jan 2025 Direct F1
transaction OM Common Stock Sale $3,522 -4,403 -0.46% $0.8000 956,413 21 Jan 2025 Direct F2
transaction OM Common Stock Sale $33,907 -42,384 -4.4% $0.8000 914,029 21 Jan 2025 Direct F3
transaction OM Common Stock Sale $14,759 -18,449 -2% $0.8000 895,580 21 Jan 2025 Direct F4
holding OM Common Stock 8,770 17 Jan 2025 Trigg Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 6, 2023, the reporting person was granted performance-based restricted stock units (PSUs) subject to the satisfaction of specified performance criteria as of December 31, 2024. The reported amount represents the number of PSUs earned by the reporting person on January 17, 2025, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive a share of common stock. These PSUs vested 50% on January 17, 2025, and the remaining 50% shall vest on December 31, 2025, subject to the reporting person's continuous service through the vesting period.
F2 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 11,706 shares of Common Stock underlying PSUs which (i) were, as previously reported, granted to the reporting person on February 2, 2022, (ii) were earned as of January 26, 2024 as certified by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria, and (iii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F3 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with 100,000 shares of Common Stock underlying PRSUs which (i) represent 50% of the target shares underlying the original award (granted on January 12, 2024, as previously reported), which were earned based on performance as of December 31, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors, and (ii) vested and were released on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F4 Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 50% of the PSUs, described in footnote (1) above, on January 17, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.